Yuxiang Ma
8PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 04, 2026
Izalontamab Brengitecan in Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations Outside of Classical EGFR Mutations: A Phase Ib Study.Huaqiang Zhou, Hongyun Zhao, Xue Hou
|Apr 22, 2025
Izalontamab (SI-B001), a Novel EGFRxHER3 Bispecific Antibody in Patients with Locally Advanced or Metastatic Epithelial Tumor: Results from First-in-Human Phase I/Ib Study.Jinhui Xue, Yuxiang Ma, Yuanyuan Zhao
|Mar 14, 2025
A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial.Yuxiang Ma, Yunpeng Yang, Yan Huang
|Feb 26, 2025
A Novel Inflammation-Marker-Based Prognostic Model for Advanced Pulmonary Lymphoepithelioma-Like Carcinoma.Xueyuan Chen, Tingting Liu, Silang Mo
|Mar 06, 2024
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma.Yuxiang Ma, Huaqiang Zhou, Fan Luo
Pageof 2